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Background. Fulminant changes in cytokine receptor signallingmight provoke severe pathological alterations aftermultiple trauma.
The aim of this study was to evaluate the posttraumatic imbalance of the innate immune system with a special focus on the
STAT/SOCS family.Methods. 20 polytraumatized patients were included. Blood samples were drawn 0 h–72 h after trauma; mRNA
expression profiles of IL-10, STAT 3, SOCS 1, and SOCS 3 were quantified by qPCR. Results. IL-10 mRNA expression increased
significantly in the early posttraumatic period. STAT 3 mRNA expressions showed a significant maximum at 6 h after trauma.
SOCS 1 levels significantly decreased 6 h–72 h after trauma. SOCS 3 levels were significantly higher in nonsurvivors 6 h after
trauma. Conclusion. We present a serial, sequential investigation in human neutrophil granulocytes of major trauma patients
evaluating mRNA expression profiles of IL-10, STAT 3, SOCS 1, and SOCS 3. Posttraumatically, immune disorder was accompanied
by a significant increase of IL-10 and STAT 3 mRNA expression, whereas SOCS 1 mRNA levels decreased after injury. We could
demonstrate that death after trauma was associated with higher SOCS 3 mRNA levels already at 6 h after trauma. To support our
results, further investigations have to evaluate protein levels of STAT/SOCS family in terms of posttraumatic immune imbalance.
1. Introduction
The immunological response to severe multiple trauma
remains a critical challenge to human health. Traumatic
injury has been known to induce substantial alterations in
immune function, which compounds both proinflamma-
tory activation known as systemic inflammation response
syndrome (SIRS) and anti-inflammatory reaction lead-
ing to immunosuppression termed as compensatory anti-
inflammatory response syndrome (CARS). In multiple
trauma, both syndromes occur simultaneously, which was
recently described as mixed antagonist response syndrome
(MARS) [1]. This serious imbalance of cell-regulated innate
immune system often contributes to posttraumatic multiple
organ dysfunctions or even multiple organ failure. With a
cell fraction of 50–60% of all leukocytes, polymorphonuclear
leukocytes have been shown to be key effector cells within
the innate inflammatory immune reaction [2]. Characteris-
tically, severe trauma leads to immediate hyperinflammatory
response with neutrophil activation followed by continuous
proinflammatory interleukin secretion (e.g., IL-6), which
usually induces an upregulation of further major anti-
inflammatory mediators, such as IL-10 [3]. Timing, control,
and extent of this mediator-associated acute-phase response
to injury appear to distinctly influence these patients’ further
clinical course. Previous mRNA expression studies of our
group could already investigate specific mRNA expression
patterns and activated signalling pathways in monocytes
after major trauma. One of our precedent genome-wide
microarray analyses could identify MAP (mitogen-activated
protein) kinase p38, JNK (Janus kinase), and c-Jun to play an
important role in trauma patients in the early posttraumatic
period and could link the increase of gene transcription in
these factors to unfavorable outcome [4, 5]. In this context,
the protein family of Signal Transducers and Activators
of Transcription (STAT) and Suppressors of Cytokine Sig-
nalling (SOCS) came into the focus of interest. Through
phosphorylation on conserved serine and tyrosine residues
STATs are activated by the Janus kinase and MAP kinase
[6]. After their activation the STAT proteins function as
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sensible sensors responding to cellular stress and modulators
of cytokine signalling by regulating their gene expression
via translocation to the nucleus [7]. STAT proteins all con-
tain a transcriptional transactivation domain as well as a
phosphorylation domain for JAKs and MAPKs, which are
both substantial for maximal STAT function [6]. Tyrosine
phosphorylation of STAT proteins occurs in response to
cytokine receptors through Janus kinases (JAKs), which is
commonly known as the JAK-STAT pathway [8]. Following
these current opinions, it is essential to gain more insight
into the complex regulation of underlying pathways in case
of posttraumatic cytokine disorder, as most cytokines have
been shown to use the Janus kinase signal transducers and
activators of transcription pathway [9]. Obviously, STAT 3 is
induced by IL-6, closely interacts with IL-10, and is associated
with the acute-phase reaction in the human liver as well
as with the maintenance of sepsis [10, 11]. SOCS genes are
one of their most considerable targets; they suppress further
cytokine receptor signalling generally in a negative feedback
loop [9, 12]. SOCS proteins also bind to JAK; particularly
SOCS 1 and SOCS 3 have been evaluated to be strong
inhibitors of JAKs.
The aim of this study was to evaluate the posttraumatic
disorder of the innate immune system with a special focus on
the STAT/SOCS protein family. We examined mRNA expres-
sion profiles of IL-10, STAT 3, SOCS 1, and SOCS 3 in neu-
trophil granulocytes after blunt multiple trauma in the early
posttraumatic period and correlated their levels to distinct
clinical conditions. Therefore, patients were distributed to
different subgroups in regard to injury severity and outcome.
2. Material and Methods
2.1. Study Design. Patients after blunt multiple trauma
(NISS > 16) aged between 18 and 70 years whowere admitted
to our level 1 trauma centre within 90 minutes after trauma
were included in this study. Signed informed consent was
obtained from each patient or his/her legal representative
over the course of time; Ethical Committee Permission
was obtained from Ludwig Maximilians University, Munich,
Germany (reference number: 012/00). Patients who did not
survive the first 24 hours after trauma and patients with
an isolated brain injury were excluded. Blood samples were
drawn immediately after admission and again 6, 12, 24, 48,
and 72 hours after trauma. Patients were assigned to different
groups regarding the two following clinical conditions: injury
severity assessed by New Injury Severity Score (with our
patient collective’s median NISS of 41 points as cutoff) and
outcome (survival of 90 days after trauma) [13]. Various
clinical data such as age, gender, injury severity, pattern
of injury, and parameters of cardiovascular function were
recorded.
2.2. Sample Collection. A total volume of 30mL of EDTA
whole blood was drawn. RBC lysis was performed by





, and 0.1mMEDTA, pH 7.2) to each 7.5mL
of EDTA-anticoagulated whole blood. Subsequently samples
were centrifuged for 10min at 450 g. To achieve quantitative
RBC removal from the cell pellets, two additional lyses and
centrifugation steps were performed.The resulting cell pellets
were then resuspended in 500mL of phosphate-buffered
saline PBS/EDTA and were further diluted for granulocyte
separation as described below.
2.3. Granulocyte Separation and RNA Isolation. Granulocyte
cell separationwas performed using amagnetic-activated cell
sorting (MACS) method, which is a special positive immune
magnetic technique for separation of various cells depending
on their surface antigens. We used anti-CD15 antibody-
coatedmicromagnetic beads for isolation of neutrophil gran-
ulocytes, as neutrophil granulocytes express CD15 antigen
on their surface. Neutrophil granulocytes attach to CD15
antibody magnetic beads and can thereby be separated pos-
itively. In detail, cells were diluted in 800mL of PBS/EDTA
buffer and incubated with 200mL of anti-CD15 antibody-
coated micromagnetic beads (Miltenyi Biotech, Auburn,
CA) for 15min at 4∘C. After incubation, the volume was
adjusted to 15mL using PBS/EDTA buffer, and the cells
were pelleted by centrifugation for 10min at 450 g. The cell
pellets were resuspended in 500mL of PBS/EDTA buffer
and were added to a preequalized high-gradient magnetic
separation column using the magnetic cell separator Mini-
MACS system (Miltenyi Biotech). The column was washed
three times. The cell suspension was lysed in 2mL of RLT
buffer (Qiagen, Hilden, Germany) containing 0.1% (v/v)
beta-mercaptoethanol and was stored at –80∘C. Total RNA
preparation from lysed granulocyteswas performed using the
RNeasyMidi Kit according to the instructions of the supplier
(Qiagen, Hilden, Germany). Nucleic acids were digested
by DNase according to manufacturer’s guidelines (RNase-
free DNase Set; Qiagen, Hilden, Germany). Concentration
of isolated RNA was determined by spectrophotometry
(260 nm, Biophotometer, Eppendorf, Hamburg, Germany).
As the integrity of total RNAhas a distinct influence on qPCR
accuracy, overall quality of RNA preparation was assessed by
electrophoresis on a denaturing agarose gel.
2.4. Quantitative Real-Time PCR (qPCR). An aliquot of
8.2 𝜇L standardized to 1 𝜇g of RNA was reverse tran-




ture’s instruction (1st Strand cDNA Synthesis Kit, Roche,
Mannheim, Germany). After denaturation (Thermocycler,
65∘C for 15min), samples were iced for 5 minutes and






reverse transcriptase and RNase inhibitor). The obtained
cDNA was diluted 1/25 with water and 10 𝜇L was used
for amplification. The quantitative analysis of target gene
expression was performed on a LightCycler by real-time PCR
using the Light Cycler Fast Start DNA Master SYBR Green
I Kit according to the manufacture’s instructions (Roche,
Mannheim, Germany). Standard and primer were designed
by Search LC (Heidelberg, Germany; LightCycler Primer
Sets). qPCR was performed by denaturation and polymerase
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activation (95∘C for 10min), amplification of qPCR products
in a 45-cycle one-step PCR including denaturation (95∘C,
10 s)/annealing (68∘C–58∘C, −0,5∘C/cycle)/extension (72∘C,
16 s) for each circle. The results of negative control samples
(NTC) were set as baseline level. Results of qPCR were stan-
dardized to this baseline level and given as copies/50 ngRNA.
Specificity of the amplification products was verified bymelt-
ing curve analysis combined with agarose gel electrophoresis.
Regarding PCR efficiency standard curves were prepared for
each gene. The slope of the standard curve marks qPCR
efficiency; slope varied from −3.3 to −3.5 in our study.
2.5. Statistical Analysis. Data were statistically analysed using
Friedman Repeated Measures Analysis of Variance on Ranks
as a method to compare several dependant spot tests to test
significant differences regarding the time points (0 h, 6 h,
12 h, 24 h, 48 h, and 72 h). In case of significant differences
we used Student-Newman-Keuls test (SNK test). Subgroups
were tested using the non-parametric Mann-Whitney-U test
(U test). The results were declared as mean values (mean)
with standard error of the mean (SEM) and were considered
statistically significant when 𝑃 < 0.05.
3. Results
3.1. Clinical Baseline Characteristics. 20 polytraumatized
patients (13 male 7 female) presenting with a NISS > 16 points
were enrolled in this study according to the abovementioned
inclusion criteria. The patients’ age raged between 18 and 70
years (mean ± SEM: 40 ± 2.8 years) with a NISS of 20 to 75
points (mean ± SEM: 40.5±3.2). Four patients (20%) died; 16
patients (80%) survived observed period of 90 days.
Retrospectively, we separated the patient collective into
two groups regarding the injury severity; that is, we used a
cutoff value of 41 points according to the median NISS in all
patients (group 1: NISS < 41, 𝑛 = 9; group 2: NISS ≥ 41,
𝑛 = 11).There were 9 patients with a NISS less than 41 points;
7 of them were male; two female. Mean age was 45.5 ± 4.0
(mean ± SEM) years; meanNISS was 27.1 ± 2.1 (Mean ± SEM)
points. Two patients in this group died within 90 days after
trauma. There were 11 patients with a NISS equal to or more
than 41 points; six of them were male and five female. Mean
age was 37.3 ± 3.5 (MW ± SEM) years; mean NISS was 52.4 ±
2.4 (mean ± SEM) points. In a second step, we separated the
collective into two groups (group A: survivors, 𝑛 = 16; group
B: nonsurvivors, 𝑛 = 4) regarding the clinical parameter
outcome (90-day survival after trauma). 16 patients survived
(11 male and 5 female with a mean age of 38.3 ± 2.9 (mean ±
SEM) years). The mean NISS was 40.3 ± 3.7 (mean ± SEM)
points in this subcollective. Four patients deceased during
this time frame (2 male and 2 female with a mean age of
48 ± 6.4 (mean ± SEM) years). Mean NISS in this subgroup
was 41.3 ± 6.9 (mean ± SEM) points. Clinical data of all 20
patients are condensed in Table 1.
3.2. IL-10 mRNA Expression Levels (Figure 1). Our study’s
results showed significantly higher mRNA expression levels
of IL-10 in granulocytes in all patients during the course of
Table 1: Clinical data of all patients (𝑛 = 20).
No. Age Gender NISS Outcome
1 34 M 57 S
2 39 F 50 S
3 32 F 66 S
4 63 F 27 Ns
5 62 M 27 S
6 45 M 19 S
7 51 M 29 S
8 25 F 57 S
9 57 M 57 S
10 51 F 57 Ns
11 39 M 17 S
12 42 F 41 S
13 40 M 41 S
14 15 M 48 S
15 32 M 43 S
16 49 M 33 Ns
17 32 M 48 Ns
18 28 F 34 S
19 39 M 24 S





the first three days after multiple trauma in contrast to the
initial value examined on admission. IL-10mRNA expression
was significantly higher in patients presenting with a NISS
less than 41 points (group 1) 24, 48, and 72 h after trauma.
Both groups (groups 1 and 2) showed a significant raise of
IL-10 mRNA expression levels at all examined time points
compared to the values detected on admission (0 h). There
were no significant differences between survivors (group A)
and nonsurvivors (group B).
3.3. STAT 3 mRNA Expression Levels (Figure 2). STAT 3
expression levels increased in the early posttraumatic period
with a significant peak at 6 h after trauma. Considering the
clinical parameters injury severity and outcome, STAT 3
mRNA levels were higher in patients with less injury severity
(group 1) than in more severely injured patients (group 2).
Patients, who died within the followup of 90 days after the
traumatic event (group B), showed a lower STAT 3 expression
directly (0 h) after trauma compared to the subcollective of
survivors (group A). However, the expression levels showed
just tendencies and no significant differences.
3.4. SOCS 1 mRNA Expression Levels (Figure 3). Regarding
the course of time (6–72 h), mRNA expression of SOCS 1
significantly decreased compared to the mRNA expression
determined initially after trauma (0 h). There were no signif-
icant differences of SOCS 1 expression profiles after dividing
the patients into different subgroups according to the clinical
conditions injury severity and outcome.
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(c)
Figure 1: Posttraumatic IL-10 mRNA expression profile after major trauma in all patients (a), depending on injury severity (NISS, (b))
and depending on outcome (survival > 90 days, (c)), ∗𝑃 < 0.05 SNK-test. IL-10 mRNA expression after blunt multiple trauma increased
significantly in the early posttraumatic period (6 h–72 h) compared to IL-10 mRNA expression immediately after trauma on admission (A).
Patients with a NISS less than 41 points expressed significantly higher IL-10 mRNA levels on admission (A), 24 h, 48 h, and 72 h after trauma,
compared to patients with a NISS between 41 and 75 points. Patients who survived the traumatic event showed a significant increase of IL-10
mRNA expression on each time point (6 h–72 h) compared to the IL-10 level detected on admission (A).
3.5. SOCS 3 mRNA Expression Levels (Figure 4). In the ob-
served period of 72 h after polytrauma, mRNA expression of
SOCS 3 was high on admission and followed by a decrease
in all patients. Six hours after the traumatic event, SOCS 3
mRNA expression was significantly higher in patients who
died (group B) within 90 days after trauma in comparison to
those who survived (group A).
4. Discussion
Major trauma entails the development of severe systemic
inflammation reaction and complex immune disorder [14].
In this context, fulminant changes in cytokine receptor
signalling may provoke severe pathological alterations, par-
ticularly in regard to immune and blood cells. Following
current opinion, various extracellular proteins, binding to
cell-surface receptors, are able to induce such changes by
altering their gene expression profile.Therefore, we evaluated
the effect of multiple injuries on mRNA expression of IL-10,
STAT 3, SOCS 1, and SOCS 3 in PMNs. Main findings in
this presented study are a significant increase of IL-10 mRNA
expression after blunt multiple trauma in all patients as well
as a significant early induction of STAT 3 mRNA six hours
after trauma. Furthermore, SOCS 1 mRNA expression levels
significantly decreased over the time compared to SOCS 1
levels measured on admission. Regarding the subgroup of
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STAT 3 survivors (group A, n = 16)
STAT 3 nonsurvivors (group B, n = 4)
(c)
Figure 2: Posttraumatic STAT 3 mRNA expression profiles after major trauma in all patients (a), depending on injury severity (NISS, (b))
and depending on outcome (survival > 90 days, (c)), ∗𝑃 < 0.05 SNK-test. STAT 3 mRNA expressions showed increasing expression levels
posttraumatically with a significant maximum level 6 h after the traumatic event in all patients (𝑛 = 20). STAT 3 mRNA expressions were
lower in patients with a NISS between 41 and 75 points compared to patients with a NISS less than 41 points. Nonsurvivors showed a higher
STAT 3 expression level within the whole posttraumatic period without significant differences.
survivors, SOCS 1 mRNA levels also significantly decreased
in the posttraumatic observation period (6 h–72 h) in com-
parison to SOCS 1 mRNA expression detected on admission.
Considering SOCS 3 mRNA levels, our study could show a
significant correlation to clinical outcome already at 6 h after
trauma as nonsurvivors expressed significantly higher levels
of SOCS 3 mRNA than survivors.
Both, STATs and SOCSs, have been shown to play a
pivotal role in case of inflammation, trauma, and burn injury
but have not yet been examined in case of multiple trauma
[9].
4.1. IL-10 mRNA Expression. We can state a significant in-
crease of IL-10 mRNA expression after blunt multiple trauma
in all patients; this dynamic of posttraumatic IL-10 pro-
duction is already described in polytraumatized patients
[15]. Comparing group 1 and group 2, mRNA expression
was significantly higher in patients suffering from moderate
injury. This result is contrary to those in other examined
trauma patient collectives. Expectedly, IL-10 mRNA expres-
sion profiles would have correlated with the magnitude of
injury [15, 16]. But still, precise nature of IL-10 response
following traumatic injury or shock remains controversial.
Some studies suggest that high IL-10 levels are deleterious
mediating immunosuppression after trauma, whereas others
consider high IL-10 levels to be beneficial [17].The potentially
beneficial underlying mechanism includes the reduction of
proinflammatory response in order to optimize tissue repair



















































SOCS 1 NISS 16–40 (group 1, n = 9)























SOCS 1 survivors (group A, n = 16)
SOCS 1 nonsurvivors (group B, n = 4)
(c)
Figure 3: Posttraumatic SOCS 1 mRNA expression profiles after major trauma in all patients (a), depending on injury severity (NISS, (b))
and depending on outcome (survival > 90 days, (c)), ∗𝑃 < 0.05 SNK-test, #𝑃 < 0.05 U test. SOCS 1 mRNA expression levels significantly
decreased after 6 h–72 h compared to SOCS 1 levels measured on admission (A). SOCS 1 mRNA levels of both subgroups (groups 1 and 2)
decreased significantly in the early posttraumatic period (6 h–72) compared to SOCS 1 levels on admission (A). There was no significant
difference between the subgroups (group 1/group 2). SOCS 1 mRNA levels significantly decreased in survivors (group A) in the posttraumatic
observation period (6 h–72 h) in comparison to SOCS 1 mRNA expression detected on admission (A).
and healing potential of the affected organism—with the need
of an executed balance between pro- and anti-inflammatory
mediators. Possibly, higher levels of anti-inflammatory IL-
10 mRNA expression levels in less injured patients (group 1)
might reflect the organism’s successful attempt to reach a
level of temporary and well-balanced posttraumatic systemic
inflammatory response in this subcollective.Thus, our study’s
results support the concept that early IL-10 overexpression
might be important in damping the postinjury immune
alteration.
4.2. STAT 3 mRNA Expression. STAT 3 mRNA expressions
showed increasing levels in the early posttraumatic period
with the significant highest level six hours after the traumatic
event. This early induction of STAT 3 mRNA expression is
in accordance with the known posttraumatic concentration
increase of various cytokines, such as IL-6, in polytrauma
patients [18]. Activated cytoplasmic STAT 3 rapidly accumu-
lates in the nucleus in response to IL-6 stimulation [19, 20].
Correlating STAT 3 mRNA expression profiles with injury
severity, our results do not show significant differences. But,
by tendency, our results show higher mRNA levels in less
severely injured patients (group 1). This result is in line with
the aforementioned results of IL-10 mRNA expression levels.
In both cases, mRNA expression levels are higher in patients
presenting with a NISS less than 41 points; this result may
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(c)
Figure 4: Posttraumatic SOCS 3mRNA expression profiles aftermajor trauma in all patients (a), depending on injury severity (NISS, (b)) and
depending on outcome (survival > 90 days, (c)), #𝑃 < 0.05 U test. SOCS 3 mRNA expressions showed a high level on admission, followed by
a decrease within the first 24 h after trauma in all polytraumatized patients. After the first day, mRNA expression levels increased again until
72 h after injury. Regarding SOCS 3 mRNA expression profiles depending on injury severity, there were no statistically significant differences
between groups 1 and 2. Nonsurvivors (group B, 𝑛 = 4) showed a significantly higher SOCS 3 mRNA expression level than survivors 6 h after
the traumatic event.
be interpreted in the same way as before. Quite possibly, the
STAT 3 depending regulation of excessive and immoderate
proinflammatory cytokine reaction after trauma is more
successful in this subcollective by mediating IL-10 induced
inhibitory effects. One reason for missing significance might
be that it is a crucial point to define cutoffs in order to
form dichotomous clinical groups. As there is no information
or recommendation for any ISS limit to our knowledge, we
chose themedian ISS value (41 points) to distinguish between
moderate and severe injury.
4.3. SOCS 1 mRNA Expression. Considering the dynamic of
SOCS 1mRNA expression patterns 72 h aftermajor trauma in
all patients, SOCS 1 levels were significantly downregulated
in the posttraumatic course of time. We could also state
a significant decrease in three subgroups, as severely and
less severely injured patients as well as survivors showed a
decrease of SOCS 1 mRNA expression compared to initial
values. SOCS 1 is implicated in the suppression of inflam-
mation by regulating innate immune cells and nonimmune
cells via interaction with Janus kinases and prevention of
catalytic activity [9, 12].Therefore, wewould have expected an
upregulation of SOCS proteins depending on high-measured
posttraumatic IL-10 and STAT 3 levels. But surprisingly,
SOCS 1 mRNA expression decreased after polytrauma in our
sample. Several studies have highlighted important SOCS
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functions as negative feedback proteins limiting chemokine-
induced migration of immune cells [21, 22]. Probably, our
results might be understood as a failed downregulation of
cytokine signalling by a missing mRNA upregulation of
SOCS 1. Another hypothetical explanation for our findings
might be the fact that there are possible discrepancies regard-
ing mRNA expression levels and protein expression levels.
Expected changes in biological active protein levelsmight not
be easily and necessarily reflected in mRNA gene expression
levels.
4.4. SOCS 3 mRNA Expression. In all patients, SOCS 3
mRNA expressions showed the highest level on admission.
Ogle et al. demonstrated that IL-10 and SOCS 3 mRNA
expression profiles were elevated after thermal injury in their
samples [12]. Our data state a significant overexpression of
IL-10 following major trauma and additionally a very high,
immediate expression of SOCS 3, followed by a decrease until
24 h after injury. In our study, this posttraumatic decrease of
SOCS 3 mRNA levels (6–72 h) was accompanied by a signif-
icant increase of STAT 3 mRNA levels directly after trauma
(6 h) and a further nonsignificant increase (12–72 h). Nor-
mally, JAK-STAT-pathway induces the expression of SOCS
3 in order to turn off IL-6 signalling. Our study’s findings
demonstrated an anticyclical kinetic of mRNA expression
profiles of STAT 3 and SOCS 3. Potentially, our result can
be interpreted as an inactivation of this aforementioned
feedback loop in a subset of posttraumatic immune disorder.
In this context, “SOCS-3 silencing” might permit constitutive
STAT 3 signalling.
Remarkably, SOCS 3 mRNA expression showed distinct
higher levels in nonsurvivors regarding the whole posttrau-
matic period with a significant overexpression of SOCS 3 in
nonsurvivors six hours after trauma. Following these results,
the overproduction of SOCS 3 in nonsurvivors in our study
was connected with adverse outcome. In a mouse model
SOCS 3deficiency seemed to protectmice fromendotoxemia;
evidently, they benefit from the reduction of inflammatory
cytokine response due to enhanced anti-inflammatory effect
of STAT 3 [23]. In our case, SOCS 3 mRNA overexpression
might be a sign for the limited beneficial immune-damping
effect of STAT 3 and is thereby associated with adverse
outcome.
4.5. Patients. In terms of gender, age, injury severity, trauma
mechanism and mortality our sample is comparable to
other reported groups (DGU TraumaRegister, 2012). As the
initial posttraumatic period appears to be predicting for
the development of SIRS and subsequent clinical outcome,
the reproduction of the course of immunological events
within this “small window” requires serial examinations to
capture the underlying complexity of posttraumatic immune
response [24, 25].
4.6. Methods. Separation of granulocytes was performed
using anti-CD15 antibody-coatedmicromagnetic beads (Mil-
tenyi Biotech, Auburn, CA, USA) in accordance with the
manufacturer’s instructions. This method is known to repro-
duce a high purity of the isolated cell fraction [26]. Different
methods reported in the literature like centrifugation fol-
lowing density gradient have been shown to lead to higher
immune cells activation [27–29]. An alternative negative
immune magnetic separation technique produces a highly
selective cell separation but is unfortunately associated with
only small cell recovery [30]. Both the methods for nuclear
mRNA and cDNA preparation and qPCR has often been
performed and described in the literature and they are known
to be well-established and valid methods [31, 32]. In our
study, we examined mRNA expression patterns in neutrophil
granulocytes, as their key role in innate immune response
after severe injury has often been constrained. With 50–
60% they cover the main part of circulating leukocytes and
influence posttraumatic immune disorder leading to organ
dysfunction of trauma patients via cytokine signalling [33].
4.7. Limitations of This Study. One limitation to our study
is that we primarily focused on mRNA expression profiles
in one cell type (PMNs). Regarding our presented results,
the evaluated mRNA gene expression levels might have
limited expressiveness concerning the biological function, as
mRNA levels do not necessarily correlate with protein levels.
Particularly cytokines such as IL-10 underlie several posttran-
scriptional regulation processes, which articulately influence
later protein concentration levels. However, advantages in
studying gene expression levels and profiles are the detection
of early intracellular changes of the transcriptome. To further
elucidate the whole complexity of this pathway, protein
level analyses and investigations on posttranslational protein
modificationswill give important further information and are
currently underway.
5. Conclusion
We present a serial, sequential investigation in human neu-
trophil granulocytes of major trauma patients evaluating the
profiles of mRNA expression of IL-10, STAT 3, SOCS 1, and
SOCS 3. Posttraumatically, immune disorder is accompa-
nied by a significant increase of IL-10 and STAT 3 mRNA
expression (6 h), whereas SOCS 1 mRNA levels decrease after
injury. We could furthermore show that death after trauma is
associated with higher SOCS 3 mRNA levels already at 6 h
after trauma. To support our results further investigations
have to focus on protein levels of STAT/SOCS family in terms
of posttraumatic immune imbalance.
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